Home > Chemotherapeutics > Vinbec
We have got your BEC
Vinblastine Sulphate
Class
Kinase Inhibitor
MOA
Vinblastine works by disrupting the microtubule structure of cells, which are important for cell division and organization of the cytoskeleton. Specifically, vinblastine binds to tubulin, which is a protein that makes up microtubules and prevents the microtubules from forming properly. This causes the cells to stop dividing and ultimately die.
In addition to disrupting microtubules, vinblastine also interferes with the formation of the mitotic spindle, which is a structure that helps to pull the chromosomes apart during cell division. This leads to abnormal chromosome segregation and ultimately cell death.
Overall, vinblastine’s mechanism of action is to disrupt the microtubule structure of cells, leading to the inhibition of cell division and ultimately cell death.
In addition to disrupting microtubules, vinblastine also interferes with the formation of the mitotic spindle, which is a structure that helps to pull the chromosomes apart during cell division. This leads to abnormal chromosome segregation and ultimately cell death.
Overall, vinblastine’s mechanism of action is to disrupt the microtubule structure of cells, leading to the inhibition of cell division and ultimately cell death.
Indications
- Generalized Hodgkin’s disease
- Lymphocytic lymphoma
- Histiocytic lymphoma
- Letterer-siwe disease
- Mycosis fungoides
- Advanced carcinoma of the testis
- Kaposi’s sarcoma
Less frequently responsive malignancies
- Choriocarcinoma resistant to other chemotherapeutic agents
- Breast cancer-unresponsive to endocrine surgery and hormonal therapy
Pack Size
1’s
Storage
2°-8° C
Available Strength
10mg Injection